Get started
Amgen Inc. 4.2% 22-FEB-2052Amgen Inc. 4.2% 22-FEB-2052Amgen Inc. 4.2% 22-FEB-2052
BondBondBond

Amgen Inc. 4.2% 22-FEB-2052

OverviewProfile

In-depth bond breakdown


Everything you need to evaluate the bond in one place. View key details, coupon payments, redemption information, issuer credit risk, and other essential metrics to better understand its potential and performance.

Key facts


Issuer
Amgen, Inc.
Issuer type
Corporate
Issue date
Feb 22, 2022
Maturity date
Feb 22, 2052
Face value
1,000.00 USD
Minimum denomination
2,000.00 USD
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Classification


Placement type
Maturity type
Duration type
Long-term
Issue allocation
Conversion option
Sinking fund
Ownership form

Credit risk assessment


Seniority rank
Pledge status
Country of risk
USA
Inflation protection
Credit parent
Credit enhancement type
Use of proceeds

Agents


Agents
Role
Commitment amount

Interest payment


Next coupon date
Coupon
4.20%
Day count basis
Coupon change type
Accrued coupon interest
Coupon frequency
Semi-annual
Coupon type
Fixed rate

Coupon payout schedule


Payment date
Accrual date
Frequency
Interest rate
Amount
Period
Upcoming payouts
Feb 22, 2052
Aug 22, 2051
Semi-annual
4.20%
21.00 USD
184 days
Aug 22, 2051
Feb 22, 2051
Semi-annual
4.20%
21.00 USD
181 days
Feb 22, 2051
Aug 22, 2050
Semi-annual
4.20%
21.00 USD
184 days

Bond redemption


Outstanding amount
‪881.72 M‬ USD
Redemption type
Next call date
Minimum call notice days

Redemption schedule


Date
Type
Price, %
Min amount